Improvement of autism spectrum disorder symptoms in three children by using gastrin-releasing peptide

Levy, 2009, Autism, Lancet, 374, 1627, 10.1016/S0140-6736(09)61376-3 2014, Prevalence of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2010, MMWR Surveill Summ, 63, 1 Olivié, 2012, Clinical practice. The medical care of children with autism, Eur J Pediatr, 171, 741, 10.1007/s00431-011-1669-1 Parellada, 2014, The neurobiology of autism spectrum disorders, Eur Psychiatry, 29, 11, 10.1016/j.eurpsy.2013.02.005 Malavolta, 2011, Peptides: important tools for the treatment of central nervous system disorders, Neuropeptides, 45, 309, 10.1016/j.npep.2011.03.001 Moody, 2004, Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications, Peptides, 25, 511, 10.1016/j.peptides.2004.02.012 Roesler, 2006, Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus, Neuropharmacology, 51, 350, 10.1016/j.neuropharm.2006.03.033 Roesler, 2012, Gastrin-releasing peptide receptors in the central nervous system: role in brain function and as a drug target, Front Endocrinol, 17, 159 Kamichi, 2005, Immunohistochemical localization of gastrin-releasing peptide receptor in the mouse brain, Brain Res, 1032, 162, 10.1016/j.brainres.2004.10.068 Garcia, 2010, Neonatal gastrin-releasing peptide receptor blockade reduces maternal odor preference in rats, Behav Brain Res, 214, 456, 10.1016/j.bbr.2010.05.038 Merali, 2014, Long-term behavioral effects of neonatal blockade of gastrin-releasing peptide receptors in rats: similarities to autism spectrum disorders, Behav Brain Res, 263, 60, 10.1016/j.bbr.2014.01.008 Presti-Torres, 2007, Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: implications for an animal model of neurodevelopmental disorders, Neuropharmacology, 52, 724, 10.1016/j.neuropharm.2006.09.020 American Psychiatric Association, 2000 Pereira, 2008, Childhood autism: translation and validation of the Childhood Autism Rating Scale for use in Brazil, J Pediatr (Rio J), 84, 487, 10.1590/S0021-75572008000700004 Amaral, 2011, The promise and the pitfalls of autism research: an introductory note for new autism researchers, Brain Res, 1380, 3, 10.1016/j.brainres.2010.11.077 2005, Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months, Am J Psychiatry, 162, 1361, 10.1176/appi.ajp.162.7.1361 Marcus, 2009, A placebo-controlled, fixed-dose study of aripiprazole in children and adolescent with irritability associated with autistic disorder, J Am Acad Child Adolescent Psychiatry, 48, 1110, 10.1097/CHI.0b013e3181b76658 McPheeters, 2011, A systematic review of medical treatments for children with autism spectrum disorders, Pediatrics, 127, e1312, 10.1542/peds.2011-0427 Ishikawa-Brush, 1997, Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3 to the SDC2 gene, Hum Mol Genet, 6, 1241, 10.1093/hmg/6.8.1241 Clive, 2001, Gastrin-releasing peptide is a potent vasodilator in humans, Clin Pharmacol Ther, 69, 252, 10.1067/mcp.2001.114888 Gutzwiller, 1994, Effect of intravenous human gastrin-releasing peptide on food intake in humans, Gastroenterology, 106, 1168, 10.1016/0016-5085(94)90006-X